-       Report 
   - January 2025
    -  150 Pages 
    Global
   
   From       €5339EUR$5,950USD£4,686GBP 
                  -       Report 
   - October 2025
    -  183 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Report 
   - October 2025
    -  190 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                -       Report 
   - November 2025
    -  376 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                -       Report 
   - August 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                 -       Report 
   - August 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - November 2025
    -  398 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                -       Report 
   - May 2025
    -  120 Pages 
    Global
   
   From       €4262EUR$4,750USD£3,741GBP 
                -       Report 
   - March 2025
    -  180 Pages 
    Global
   
   From       €4038EUR$4,500USD£3,544GBP 
                -       Report 
   - November 2024
    -  157 Pages 
    Global
   
   From       €2243EUR$2,500USD£1,969GBP 
                  -       Report 
   - August 2025
    -  150 Pages 
    Global
   
   From       €3013EUR$3,358USD£2,644GBP 
      €3544EUR$3,950USD£3,111GBP 
                -       Report 
   - January 2025
    -  407 Pages 
    Global
   
   From       €4442EUR$4,950USD£3,898GBP 
                  -       Report 
   - October 2025
    -  184 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Report 
   - August 2025
    -  187 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                  -       Report 
   - October 2025
    -  182 Pages 
    Global
   
   From       €3181EUR$3,545USD£2,792GBP 
      €3535EUR$3,939USD£3,102GBP 
                -       Report 
   - August 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - August 2025
    -  250 Pages 
    Global
   
   From       €4029EUR$4,490USD£3,536GBP 
                -       Report 
   - November 2025
    -  263 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
                  -       Report 
   - June 2025
    -  150 Pages 
    Global
   
   From       €2287EUR$2,549USD£2,008GBP 
      €2691EUR$2,999USD£2,362GBP 
                -       Report 
   - November 2025
    -  477 Pages 
    Global
   
   From       €5249EUR$5,850USD£4,607GBP 
             
         The Swine Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and production of vaccines for swine. Vaccines are used to protect swine from a variety of diseases, including Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus (PCV), and Classical Swine Fever (CSF). Vaccines are typically administered to swine through injection or oral administration.
The Swine Vaccine market is highly competitive, with a number of companies offering    a variety of products. Companies in the market include Merck Animal Health, Zoetis, Elanco, Boehringer Ingelheim, and Ceva Sante Animale. These companies offer a range of products, including vaccines for PRRS, PCV, and CSF, as well as other vaccines for swine. Show Less   Read more